414 related articles for article (PubMed ID: 30003321)
1. Interactions among myeloid regulatory cells in cancer.
Umansky V; Adema GJ; Baran J; Brandau S; Van Ginderachter JA; Hu X; Jablonska J; Mojsilovic S; Papadaki HA; Pico de Coaña Y; Santegoets KCM; Santibanez JF; Serre K; Si Y; Sieminska I; Velegraki M; Fridlender ZG
Cancer Immunol Immunother; 2019 Apr; 68(4):645-660. PubMed ID: 30003321
[TBL] [Abstract][Full Text] [Related]
2. Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation.
Amodio G; Cichy J; Conde P; Matteoli G; Moreau A; Ochando J; Oral BH; Pekarova M; Ryan EJ; Roth J; Sohrabi Y; Cuturi MC; Gregori S
Cancer Immunol Immunother; 2019 Apr; 68(4):661-672. PubMed ID: 30357490
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
Veglia F; Sanseviero E; Gabrilovich DI
Nat Rev Immunol; 2021 Aug; 21(8):485-498. PubMed ID: 33526920
[TBL] [Abstract][Full Text] [Related]
4. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
5. Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.
Abrams SI; Netherby CS; Twum DY; Messmer MN
J Interferon Cytokine Res; 2016 Jul; 36(7):442-53. PubMed ID: 27379866
[TBL] [Abstract][Full Text] [Related]
6. Plasticity of myeloid-derived suppressor cells in cancer.
Tcyganov E; Mastio J; Chen E; Gabrilovich DI
Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
[TBL] [Abstract][Full Text] [Related]
7. Tuning the Tumor Myeloid Microenvironment to Fight Cancer.
Jahchan NS; Mujal AM; Pollack JL; Binnewies M; Sriram V; Reyno L; Krummel MF
Front Immunol; 2019; 10():1611. PubMed ID: 31402908
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal relationship between myeloid-derived suppressor cells and T cells.
Nagaraj S; Youn JI; Gabrilovich DI
J Immunol; 2013 Jul; 191(1):17-23. PubMed ID: 23794702
[TBL] [Abstract][Full Text] [Related]
9. Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy.
Wennerberg E; Lundqvist A; Mao Y; Mougiakakos D
Front Immunol; 2021; 12():718844. PubMed ID: 34276709
[No Abstract] [Full Text] [Related]
10. Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC.
Giroud P; Renaudineau S; Gudefin L; Calcei A; Menguy T; Rozan C; Mizrahi J; Caux C; Duong V; Valladeau-Guilemond J
Front Immunol; 2020; 11():564133. PubMed ID: 33101282
[TBL] [Abstract][Full Text] [Related]
11. Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment.
Haas L; Obenauf AC
Front Immunol; 2019; 10():2746. PubMed ID: 31849950
[TBL] [Abstract][Full Text] [Related]
12. Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy.
Clappaert EJ; Murgaski A; Van Damme H; Kiss M; Laoui D
Front Immunol; 2018; 9():2250. PubMed ID: 30349530
[TBL] [Abstract][Full Text] [Related]
13. Decidualization Process Induces Maternal Monocytes to Tolerogenic IL-10-Producing Dendritic Cells (DC-10).
Gori S; Soczewski E; Fernández L; Grasso E; Gallino L; Merech F; Colado A; Borge M; Pérez Leirós C; Salamone G; Ramhorst R
Front Immunol; 2020; 11():1571. PubMed ID: 32973738
[TBL] [Abstract][Full Text] [Related]
14. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?
Brandau S; Moses K; Lang S
Semin Cancer Biol; 2013 Jun; 23(3):171-82. PubMed ID: 23459190
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
Ostrand-Rosenberg S; Sinha P; Beury DW; Clements VK
Semin Cancer Biol; 2012 Aug; 22(4):275-81. PubMed ID: 22313874
[TBL] [Abstract][Full Text] [Related]
16. microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.
Daveri E; Vergani E; Shahaj E; Bergamaschi L; La Magra S; Dosi M; Castelli C; Rodolfo M; Rivoltini L; Vallacchi V; Huber V
Front Immunol; 2020; 11():1214. PubMed ID: 32793185
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine.
Yaseen MM; Abuharfeil NM; Darmani H; Daoud A
Open Biol; 2020 Sep; 10(9):200111. PubMed ID: 32931721
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-Derived Suppressor Cells.
Gabrilovich DI
Cancer Immunol Res; 2017 Jan; 5(1):3-8. PubMed ID: 28052991
[TBL] [Abstract][Full Text] [Related]
19. On the origin of myeloid-derived suppressor cells.
Millrud CR; Bergenfelz C; Leandersson K
Oncotarget; 2017 Jan; 8(2):3649-3665. PubMed ID: 27690299
[TBL] [Abstract][Full Text] [Related]
20. Myeloid cell heterogeneity in cancer: not a single cell alike.
Kiss M; Van Gassen S; Movahedi K; Saeys Y; Laoui D
Cell Immunol; 2018 Aug; 330():188-201. PubMed ID: 29482836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
